A decision to declare an international public health emergency by the World Health Organization (WHO) this morning is widely expected as the number of confirmed novel coronavirus cases and death toll continue to rise in China.

However, WHO’s statement serves to soothe market jitters as it ‘opposes any restriction on travel and trade against China’. The chairman of WHO praised Chinese efforts to control the epidemic as ‘very impressive’.

US equity indices rebounded in the last hours of trading, lifted by financials (+1.25%), consumer staples (+1.05%), utilities (+0.89%) and information technology (+0.88%), whereas communication (-0.79%), healthcare (-0.78%), materials (-0.59%) were among the worst performing in S&P 500 sectors.

Tesla’s share price jumped over 10% to US$ 640.8 as its latest earnings smashed market consensus. The EPS came in at US$ 2.14, comparing to US$ 1.72 forecast. The company aims to produce at least half a million vehicles this year, which is 36% higher than last year’s output. The coronavirus outbreak in China, however, may put some uncertainty over its production in Shanghai and demand outlook in the first quarter of this year.

Today, traders will eye China’s official manufacturing PMI reading released at 9:00am for clues of economic stabilization. Global cyclical upswing was observed in manufacturing PMI data in the past few months. How strong is this recovery against an abrupt outbreak of health crisis in Asia-Pacific remains to be seen.

The ramifications of the coronavirus go beyond the many people who are infected and under treatment. There are also indirect impacts of the decisions that many millions of individuals make to minimize the chance of getting infected. These include reduced frequency of travel, shopping, dining, entertainment and investment, which may cause heavy losses to businesses who are associated with these affected industries.

Hong Kong 50 - Cash

CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.



CMC Markets Singapore may provide or make available research analysis or reports prepared or issued by entities within the CMC Markets group of companies, located and regulated under the laws in a foreign jurisdictions, in accordance with regulation 32C of the Financial Advisers Regulations. Where such information is issued or promulgated to a person who is not an accredited investor, expert investor or institutional investor, CMC Markets Singapore accepts legal responsibility for the contents of the analysis or report, to the extent required by law. Recipients of such information who are resident in Singapore may contact CMC Markets Singapore on 1800 559 6000 for any matters arising from or in connection with the information.